About Yield10 Bioscience (NASDAQ:YTEN)
Yield10 Bioscience, Inc., an agricultural bioscience company, engages in developing disruptive technologies for enhancing crop yield in the United States and Canada. The company, through its Smart Carbon Grid for Crops and T3 platforms, is involved in improving fundamental crop yield through enhanced photosynthetic carbon capture, as well as increased carbon utilization efficiency to increase seed yield. The company was formerly known as Metabolix, Inc. and changed its name to Yield10 Bioscience, Inc. in January 2017. Yield10 Bioscience, Inc. was founded in 1992 and is headquartered in Woburn, Massachusetts.
Industry, Sector and Symbol
Industry Miscellaneous plastics products
Trailing P/E Ratio-0.43
Forward P/E RatioN/A
Sales & Book Value
Price / Sales15.09
Price / CashN/A
Book Value$1.48 per share
Price / Book0.96
EPS (Most Recent Fiscal Year)($3.29)
Return on Equity-131.88%
Return on Assets-90.19%
Yield10 Bioscience (NASDAQ:YTEN) Frequently Asked Questions
What is Yield10 Bioscience's stock symbol?
Yield10 Bioscience trades on the NASDAQ under the ticker symbol "YTEN."
When did Yield10 Bioscience's stock split? How did Yield10 Bioscience's stock split work?
Shares of Yield10 Bioscience reverse split before market open on Tuesday, May 30th 2017. The 1-10 reverse split was announced on Friday, May 26th 2017. The number of shares owned by shareholders was adjusted after the market closes on Friday, May 26th 2017. An investor that had 100 shares of Yield10 Bioscience stock prior to the reverse split would have 10 shares after the split.
How were Yield10 Bioscience's earnings last quarter?
Yield10 Bioscience Inc (NASDAQ:YTEN) issued its quarterly earnings data on Thursday, May, 10th. The specialty chemicals company reported ($0.24) EPS for the quarter. The specialty chemicals company earned $0.06 million during the quarter. Yield10 Bioscience had a negative return on equity of 131.88% and a negative net margin of 1,410.88%. View Yield10 Bioscience's Earnings History.
Who are some of Yield10 Bioscience's key competitors?
Some companies that are related to Yield10 Bioscience include Senomyx (SNMX), Royal Hawaiian Orchards Lp Common Stock (NNUTU), TDH (PETZ), Willamette Valley Vineyards (WVVI), Mamamancini's (MMMB), Alkaline Water (WTER), Eastside Distilling (EAST), RiceBran Technologies (RIBT), China New Borun (BORN), Ocean Bio-Chem (OBCI), Coffee (JVA), PwrCor (PWCO), Big Rock Brewery (BRBMF), GLG Life Tech (GLGLF) and Burcon Nutrascience (BUR).
Who are Yield10 Bioscience's key executives?
Yield10 Bioscience's management team includes the folowing people:
- Dr. Oliver P. Peoples Ph.D., Co-Founder, Pres, CEO & Director (Age 60)
- Dr. Anthony J. Sinskey, Co-Founder & Director (Age 78)
- Dr. Kristi Snell, Chief Science Officer & VP of Research (Age 50)
- Ms. Lynne H. Brum, VP - Planning & Communications and Sec. (Age 54)
- Mr. Charles B. Haaser, Chief Accounting Officer, Principal Financial Officer, VP of Fin. & Treasurer (Age 62)
Has Yield10 Bioscience been receiving favorable news coverage?
Headlines about YTEN stock have been trending somewhat positive recently, Accern Sentiment Analysis reports. The research group scores the sentiment of news coverage by analyzing more than 20 million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Yield10 Bioscience earned a media sentiment score of 0.15 on Accern's scale. They also gave media headlines about the specialty chemicals company an impact score of 46.31 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock's share price in the near future.
How do I buy shares of Yield10 Bioscience?
Shares of YTEN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Yield10 Bioscience's stock price today?
One share of YTEN stock can currently be purchased for approximately $1.42.
How big of a company is Yield10 Bioscience?
Yield10 Bioscience has a market capitalization of $14.19 million and generates $940,000.00 in revenue each year. The specialty chemicals company earns $-9,390,000.00 in net income (profit) each year or ($3.29) on an earnings per share basis. Yield10 Bioscience employs 20 workers across the globe.
How can I contact Yield10 Bioscience?
Yield10 Bioscience's mailing address is 19 PRESIDENTIAL WAY, WOBURN MA, 01801. The specialty chemicals company can be reached via phone at 617-583-1700 or via email at [email protected]
MarketBeat Community Rating for Yield10 Bioscience (YTEN)MarketBeat's community ratings are surveys of what our community members think about Yield10 Bioscience and other stocks. Vote "Outperform" if you believe YTEN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe YTEN will underperform the S&P 500 over the long term. You may vote once every thirty days.